Back

mr. ing. T.U.U. (Karijn) Vels

mr. ing. T.U.U. (Karijn) Vels

Full Professor

Show full profile

Research Output (97)

Immune checkpoint inhibitor–associated sarcoidosis:A usually benign disease that does not require immunotherapy discontinuation

Chanson Noémie, Ramos-Casals Manuel, Pundole Xerxes, Suijkerbuijk Karijn, José de Barros e Silva Milton, Lidar Merav, Benesova Karolina, Leipe Jan, Acar-Denizli Nihan, Pradère Pauline, Michot Jean Marie, Voisin Anne Laure, Suárez-Almazor Maria, Radstake Timothy R.D., Fernandes Moça Trevisani Virginia, Schulze-Koops Hendrik, Melin Audrey, Robert Caroline, Mariette Xavier, Baughman Robert P., Lambotte Olivier, Kostine Marie, Khamashta Munther A., Calabrese Leonard, Suárez-Almazor Maria, Baldini Chiara, Bingham Clifton O., Gottenberg Jacques Eric, Schaeverbeke Thierry, Brito-Zerón Pilar, Flores-Chávez Alejandra, , , , , , Nov 2021, In: European Journal of Cancer. 158 , p. 208-216 9 p.

Hospital variation in cancer treatments and survival outcomes of advanced melanoma patients:Nationwide quality assurance in the netherlands

van Breeschoten Jesper, van den Eertwegh Alfonsus J.M., de Wreede Liesbeth C., Hilarius Doranne L., van Zwet Erik W., Haanen John B., Blank Christian U., Aarts Maureen J.B., van den Berkmortel Franchette W.P.J., de Groot Jan Willem B., Hospers Geke A.P., Kapiteijn Ellen, Piersma Djura, van Rijn Rozemarijn S., Stevense‐Den Boer Marion A.M., van der Veldt Astrid A.M., Vreugdenhil Gerard, Boers‐sonderen Marye J., Suijkerbuijk Karijn P.M., Wouters Michel W.J.M. 11 Oct 2021, In: Cancers. 13 , p. 1-12 12 p.

Sex-Based Differences in Treatment with Immune Checkpoint Inhibition and Targeted Therapy for Advanced Melanoma:A Nationwide Cohort Study

van der Kooij Monique K, Dekkers Olaf M, Aarts Maureen J B, van den Berkmortel Franchette W P J, Boers-Sonderen Marye J, de Groot Jan Willem B, Hospers Geke A P, Piersma Djura, van Rijn Rozemarijn S, Suijkerbuijk Karijn P M, Westgeest Hans M, van der Veldt Astrid A M, Vreugdenhil Gerard, Wilgenhof Sofie, Wouters Michel W J M, Haanen John B A G, van den Eertwegh Alfonsus J M, Kapiteijn Ellen 16 Sep 2021, In: Cancers. 13 , p. 1-13

IN RESPONSE: Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease:A cohort study

van der Kooij Monique K, Suijkerbuijk Karijn P M, Dekkers Olaf M, Kapiteijn Ellen 1 Sep 2021, In: Annals of Internal Medicine. 174 , p. 1345-1346 2 p.

TNF inhibition for immune checkpoint inhibitor-induced irAEs:the jury is still out

Suijkerbuijk Karijn P M, Verheijden Rik J 8 Jun 2021, In: Nature Reviews. Rheumatology. 17 , p. 505 1 p.

Toxicity, response and survival in older patients with metastatic melanoma treated with checkpoint inhibitors<sup>†</sup>

de Glas Nienke A., Bastiaannet Esther, van den Bos Frederiek, Mooijaart Simon P., van der Veldt Astrid A.M., Suijkerbuijk Karlijn P.M., Aarts Maureen J.B., van den Berkmortel Franchette W.P.J., Blank Christian U., Boers-Sonderen Marye J., van den Eertwegh Alfonsus J.M., de Groot Jan Willem B., Haanen John B.A.G., Hospers Geke A.P., Jalving Hilde, Piersma Djura, van Rijn Rozemarijn S., Ten Tije Albert J., Vreugdenhil Gerard, Wouters Michel W.J.M., Portielje Johanneke E.A., Kapiteijn Ellen W. 1 Jun 2021, In: Cancers. 13

Outcomes for systemic therapy in older patients with metastatic melanoma:Results from the Dutch Melanoma Treatment Registry

Jochems Anouk, Bastiaannet Esther, Aarts Maureen J B, van Akkooi Alexander C J, van den Berkmortel Franchette W P J, Boers-Sonderen Marye J, van den Eertwegh Alfonsus J M, de Glas Nienke G, de Groot Jan Willem B, Haanen John B A G, Hospers Geke A P, van der Hoeven Jacobus J M, Piersma Djura, van Rijn Rozemarijn S, Suijkerbuijk Karijn P M, Ten Tije Albert J, van der Veldt Astrid A M, Vreugdenhil Gerard, van Zeijl Michiel C T, Kapiteijn Ellen, Wouters Michel W J M 18 May 2021, In: Journal of geriatric oncology. 12 , p. 1031-1038 8 p.

The role of local therapy in the treatment of solitary melanoma progression on immune checkpoint inhibition:A multicentre retrospective analysis

Versluis Judith M, Hendriks Anne M, Weppler Alison M, Brown Lauren J, de Joode Karlijn, Suijkerbuijk Karijn P M, Zimmer Lisa, Kapiteijn Ellen W, Allayous Clara, Johnson Douglas B, Hepner Adriana, Mangana Joanna, Bhave Prachi, Jansen Yanina J L, Trojaniello Claudia, Atkinson Victoria, Storey Lucy, Lorigan Paul, Ascierto Paolo A, Neyns Bart, Haydon Andrew, Menzies Alexander M, Long Georgina V, Lebbe Celeste, van der Veldt Astrid A M, Carlino Matteo S, Sandhu Shahneen, van Tinteren Harm, de Vries Elisabeth G E, Blank Christian U, Jalving Mathilde 7 May 2021, In: European Journal of Cancer. 151 , p. 72-83 12 p.

High discordance rate in assessing sentinel node positivity in cutaneous melanoma:Expert review may reduce unjustified adjuvant treatment

El Sharouni Mary Ann, Laeijendecker Annelien E., Suijkerbuijk Karijn PM, Witkamp Arjen J., Sigurdsson Vigfús, van Diest Paul J., van Gils Carla H., Blokx Willeke AM 10 Apr 2021, In: European Journal of Cancer. 149 , p. 105-113 9 p.

Checkpoint inhibition:protecting against or predisposing for second primary tumors?

Suijkerbuijk K P M, May A M, van Eijs M J M 29 Mar 2021, In: Annals of oncology : official journal of the European Society for Medical Oncology. 32 , p. 935-935 1 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not